Chemoradiation
Chemoradiation is an intervention with 45 clinical trials. Currently 16 active trials ongoing. Historical success rate of 64.7%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
25
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
57.9%
11 of 19 finished
42.1%
8 ended early
16
trials recruiting
45
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
Clinical Trials (45)
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
FOLFIRINOX + NIS793 in Pancreatic Cancer
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
Induction Chemotherapy for Locally Advanced Esophageal Cancer
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers
Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 45